Aspira Women's Health Inc. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aspira Women's Health Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Aspira Women's Health Inc. Return On Equity for the quarter ending June 30, 2024 was 788 %.
  • Aspira Women's Health Inc. annual Return On Equity for 2023 was 2.45K %.
  • Aspira Women's Health Inc. annual Return On Equity for 2022 was -221 %, a 193% decline from 2021.
  • Aspira Women's Health Inc. annual Return On Equity for 2021 was -75.5 %, a 61.2% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 788 +1.25K Apr 1, 2024 Jun 30, 2024
Q1 2024 1.2K +1.53K Jan 1, 2024 Mar 31, 2024
Q4 2023 2.45K +2.67K Oct 1, 2023 Dec 31, 2023
Q3 2023 -1.1K -922 -520% Jul 1, 2023 Sep 30, 2023
Q2 2023 -461 -323 -233% Apr 1, 2023 Jun 30, 2023
Q1 2023 -329 -227 -222% Jan 1, 2023 Mar 31, 2023
Q4 2022 -221 -146 -193% Oct 1, 2022 Dec 31, 2022
Q3 2022 -177 -99.3 -127% Jul 1, 2022 Sep 30, 2022
Q2 2022 -138 -62.7 -82.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -102 -6.06 -6.32% Jan 1, 2022 Mar 31, 2022
Q4 2021 -75.5 +119 +61.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -78.1 +91.6 +54% Jul 1, 2021 Sep 30, 2021
Q2 2021 -75.7 +102 +57.5% Apr 1, 2021 Jun 30, 2021
Q1 2021 -96 +59.3 +38.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -194 -32.2 -19.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 -170 -6.6 -4.05% Jul 1, 2020 Sep 30, 2020
Q2 2020 -178 -18.5 -11.6% Apr 1, 2020 Jun 30, 2020
Q1 2020 -155 -4.95 -3.29% Jan 1, 2020 Mar 31, 2020
Q4 2019 -162 -11.5 -7.61% Oct 1, 2019 Dec 31, 2019
Q3 2019 -163 +11.1 +6.37% Jul 1, 2019 Sep 30, 2019
Q2 2019 -159 +41.3 +20.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -150 +133 +46.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -151 +55.1 +26.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 -174 +26.1 +13% Jul 1, 2018 Sep 30, 2018
Q2 2018 -201 +14.3 +6.64% Apr 1, 2018 Jun 30, 2018
Q1 2018 -283 -87.5 -44.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -206 -21.3 -11.5% Oct 1, 2017 Dec 31, 2017
Q3 2017 -200 -52.2 -35.3% Jul 1, 2017 Sep 30, 2017
Q2 2017 -215 -94 -77.7% Apr 1, 2017 Jun 30, 2017
Q1 2017 -195 -66.6 -51.8% Jan 1, 2017 Mar 31, 2017
Q4 2016 -185 -65.3 -54.7% Oct 1, 2016 Dec 31, 2016
Q3 2016 -148 -37.3 -33.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -121 +11.6 +8.76% Apr 1, 2016 Jun 30, 2016
Q1 2016 -129 -9.15 -7.65% Jan 1, 2016 Mar 31, 2016
Q4 2015 -119 -13.4 -12.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 -111 -26 -30.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -133 -62.3 -88.4% Apr 1, 2015 Jun 30, 2015
Q1 2015 -120 -63.1 -112% Jan 1, 2015 Mar 31, 2015
Q4 2014 -106 -37.9 -55.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 -84.7 +28.1 +24.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 -70.4 +59.8 +45.9% Apr 1, 2014 Jun 30, 2014
Q1 2014 -56.5 +106 +65.3% Jan 1, 2014 Mar 31, 2014
Q4 2013 -68.1 +42 +38.2% Oct 1, 2013 Dec 31, 2013
Q3 2013 -113 -0.28 -0.25% Jul 1, 2013 Sep 30, 2013
Q2 2013 -130 -13.2 -11.2% Apr 1, 2013 Jun 30, 2013
Q1 2013 -163 -39.8 -32.4% Jan 1, 2013 Mar 31, 2013
Q4 2012 -110 Oct 1, 2012 Dec 31, 2012
Q3 2012 -113 Jul 1, 2012 Sep 30, 2012
Q2 2012 -117 Apr 1, 2012 Jun 30, 2012
Q1 2012 -123 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.